SBIR/STTR Research Award
SBIR TOPIC 107, PHASE I - TRANSCATHETER POTTS SHUNT
Award amount
$399,352Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- TRANSMURAL SYSTEMS LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NVTWAUS1JEH5
- Solicitation number
- Not reported
- Topic code
- NHLBI
Research abstract
The goal of Phase I is to develop and test a Transcatheter Potts Shunt prototype system in vivoThe deliverable is a catheter system to establish a non surgical Potts Shunttranscatheter pulmonary to aortic anastomosisto treat refractory pulmonary artery hypertensionPhase I will focus on mechanical and biological performance of the proposed endografttaking into account mechanical strength required for the applicationgeometry of the access vessels and geometry and morphology of target vesselsfeatures to accommodate late post dilatation to achieve larger size in growing childrenimplantationand visualization strategies
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- SBIR TOPIC 107, PHASE II, TRANSCATHETER POTTS SHUNT
- SBIR TOPIC 112, FAST-TRACK, INTRAMYOCARDIAL SUTURE ANNULOPLASTY SYSTEM (""MIRTH"" AND ""SCIMITAR"" DEVICES)
- AWARD SBIR TOPIC #110 PHASE II-MRI MYOCARDIAL BIOPSY SYSTEM
- SBIR TOPIC 112, FAST-TRACK, INTRAMYOCARDIAL SUTURE ANNULOPLASTY SYSTEM (""MIRTH"" AND ""SCIMITAR"" DEVICES)
- Phase IIB Transmural Systems Transcatheter Cavopulmonary Bypass Endograft
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY
- Head Up CPR and Aortic Occlusion to Improve Survival after Refractory Cardiac Arrest
- Free-Breathing Dynamic Cardiopulmonary Function Imaging System to use with Xenon MRI
- The Next Wave of Asthma Therapeutics
- Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications
Research funding history
21 SBIR/STTR records share this UEI (2015–2023). Reported award amounts total $36,729,432. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services